- Poster presentation
- Open Access
MRI assessment of cardiomyopathy in Taiwan Chinese late-onset Fabry mutation (IVS4+919G>A)
© Chang et al; licensee BioMed Central Ltd. 2015
- Published: 3 February 2015
- Fabry Disease
- Endomyocardial Biopsy
- Myocardial Segment
- Short Axis View
- Residual Enzyme Activity
Fabry disease is a rare X-linked disorder characterized by deficiency ofα-galactosidase A, leading to progressive accumulation of glycosphingolipid in various organs, including the heart. Recently, several later-onset phenotypes of Fabry disease with residual enzyme activity have been identified. In Taiwan, several recent studies pointed out a surprisingly high incidence of a later onset Fabry mutation (IVS4+919G>A) and there is a lack of information about its cardiac MR appearance in the literature. We aim to present the cardiac MR appearances of this subtype of Fabry disease and compare them with the classic type.
A total of 12 patients (9 males and 3 females) were enrolled in this study. They underwent endomyocardial biopsy as well as MR study from July 2013 to September 2014 and were proved to be Fabry mutation (IVS4+919G>A). We recorded the location of delayed myocardial enhancement according to modified AHA 16-segment model and measured left ventricular (LV) wall thickness of each segment in short axis view at the end diastole. We categorized these patients into three groups (Group I, II, III) according to their myocardial thickness(all segments<12mm, at least one segment 12~16mm, at least one segment>16mm, respectively ). Among the all patients, we used Χ square test to evaluate if there was significant difference in presence of delayed enhancement according to different myocardial wall thickness.
There were 12 patients with 192 myocardial segments (male: 144 segments, female: 48 segments) under evaluation. There were 4 patients in Group III with 22 segments>16mm, 4 patients in Group II with 5 segments in range of 13~16mm. The remained 4 patients were in Group I. in Group III were. In Group III, there were 15 segments>16mm involving the septum and 13 segments in range of 13~16mm. Besides, there were 37 segments with delayed enhancement in Group III, with 14 in posteriolateral wall, 13 in anterior wall and 10 involving the septum. In group I and II, two patients with 4 segments demonstrated delayed enhancement and the 4 segments (segment 4, 10, 6, 11) are all in the normal range of thickness(<12mm). In the Χ square test evaluation, there was significant difference in presence of delayed enhancement dependent on various myocardial wall thickness (P<0.05).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.